Ancorex Therapeutics is categorized under Research and Development Laboratories in San Diego, CA and active since 2011.
Ancorex Therapeutics was established in 2011, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Robert Zaugg at the company’s single location by writing to 3010 Science Park Road, San Diego, California CA 92121 or by phoning (858) 336-5409. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Ancorex Therapeutics |
| Contact Person: | Robert Zaugg |
| Address: | 3010 Science Park Road, San Diego, California 92121 |
| Phone Number: | (858) 336-5409 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research and Development Laboratories |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Ancorex Therapeutics was started in 2011 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Robert Zaugg for inquiries that concern Ancorex Therapeutics by calling the company number (858) 336-5409, as your correspondence is most welcome. Additionally, the physical location of the single location of Ancorex Therapeutics can be found at the coordinates 32.901837,-117.242456 as well as the street address 3010 Science Park Road in San Diego, California 92121.
For its online presence, you may visit Ancorex Therapeutics’s website at and engage with its social media outlets through on Twitter and on Facebook.